The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > BUSINESS
BUSINESS
- Xtandi Demonstrates Clinical Benefit for Advanced Breast Cancer in PII Study: Astellas
December 17, 2014
- Battle Begins for Blopress Generics
December 16, 2014
- Eliquis the First NOAC with Safety Information Announced for Over 100,000 Patients
December 16, 2014
- Kaketsuken, Teijin Pharma Initiate Voluntary Recall of Venilon after Wool Fiber Found in Vial of Dissolved Product
December 16, 2014
- Otsuka Initiates Tender Offer to Acquire All Outstanding Shares of Avanir for US$17 per Share
December 16, 2014
- ViiV Healthcare Files NDA for Triple-Combination HIV Agent in Japan
December 16, 2014
- With Mandatory CDISC-Based Submission Looming, CRO A2 Sees Soaring Orders from Japanese Drug Makers
December 16, 2014
- Sanofi Reiterates Alert on Proper Use of Jevtana; Five Deaths Reported Since Launch in September
December 15, 2014
- Sumitomo Dainippon Aims for NDA Filing for ADHD Treatment Dasotraline in FY2017 in US
December 15, 2014
- Kyowa Kirin Aims to Score Global Sales of 20 Billion Yen for Poteligeo in a Few Years: President Hanai
December 15, 2014
- Astellas Reduces Sales Offices from 159 to 109, Aims to Better Respond to Specific Needs in Each Region: President Hatanaka
December 12, 2014
- Hanshin Dispensing Holding Joins Forces with Convenience Store Lawson
December 12, 2014
- Brexpiprazole Improves Schizophrenia in PIII: Otsuka, Lundbeck
December 11, 2014
- Eisai’s Orexin Receptor Antagonist Improves Sleep Initiation, Maintenance in PII Study
December 11, 2014
- Blopress AG Will Lose Steam after Launch of Rival Generics, Sawai Pres. Predicts
December 11, 2014
- Ono, Kyowa Kirin, BMS to Conduct PI Study of Opdivo and Poteligeo as Combination Therapy in Patients with Solid Tumors
December 11, 2014
- Humanized Bispecific Antibody for Hemophilia A Effective in PI Study: Chugai
December 10, 2014
- Alfresa to Acquire More Shares of Pharmacy Chain Operator
December 10, 2014
- Ethical Drug Sales 1.1%, in October: Crecon Report
December 10, 2014
- Efficacy of Lenalidomide in Treatment-Naïve Patients with Multiple Myeloma Confirmed in Domestic PII Study: Celgene
December 10, 2014
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…